Workflow
Roku(ROKU) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
Roku (ROKU) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Conrad Grodd - Vice President, Investor RelationsCory Carpenter - Internet Equity ResearchAnthony Wood - Founder, Chairman & CEODan Jedda - Chief Financial OfficerCharlie Collier - President of Roku MediaJustin Patterson - Managing DirectorMustafa Ozgen - President - Devices, Products & TechnologyJames Heaney - SVP - Equity Research Conference Call Participants Brent Navon - AnalystVasily Karasyov - Founder & Senior AnalystLaura ...
Columbia(COLM) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
Columbia Sportswear Company (COLM) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Andrew Burns - VP - IR & StrategicTim Boyle - Chairman, President and CEOJim Swanson - EVP & CFOPeter McGoldrick - Equity Research AssociateKrista Zuber - DirectorPaul Lejuez - Managing DirectorPaul Kearney - VP - Equity ResearchAlexander Perry - Director, Equity ResearchMauricio Serna - Executive Director Conference Call Participants Laurent Vasilescu - Managing Director & Senior Equity AnalystMitch Kumme ...
LeMaitre Vascular(LMAT) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
LeMaitre Vascular (LMAT) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Dorian LeBlanc - CFOGeorge LeMaitre - Chairman & CEOShaymus Contorno - Equity Research AssociateDavid Roberts - President & DirectorMichael Petusky - Managing DirectorRick Wise - Managing Director - Medical Technology & SuppliesDaniel Stauder - Director - Equity Research Conference Call Participants Michael Sarcone - AnalystFrank Takkinen - Senior Research AnalystJim Sidoti - AnalystBrett Fishbin - Vice President & ...
Rimini Street(RMNI) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
Rimini Street (RMNI) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Dean Pohl - VP of Investor Relations & TreasurerSeth Ravin - Founder, Chairman, CEO & PresidentMichael Perica - EVP, CFO & Principal Accounting OfficerBrian Kinstlinger - MD, Director of Research & Head of Technology ResearchCole Erskine - Vice President - Equity Research Operator Good afternoon, ladies and gentlemen, and welcome to the Rimini Street Q1 twenty twenty five Earnings Conference Call. At this time, all line ...
Floor & Decor(FND) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
Floor & Decor (FND) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Wayne Hood - Senior Vice President of IRThomas Taylor - Chief Executive OfficerBradley Paulsen - PresidentBryan Langley - Executive VP & CFOErsan Sayman - EVP of MerchandisingSteven Forbes - Senior Managing DirectorSteven Zaccone - Director, Equity Research, Hardlines RetailMax Rakhlenko - Managing DirectorChuck Grom - Managing Director Conference Call Participants Seth Sigman - Managing Director, Senior Equity Research ...
LeMaitre Vascular(LMAT) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
LeMaitre Vascular (LMAT) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Dorian LeBlanc - CFOGeorge LeMaitre - Chairman & CEOShaymus Contorno - Equity Research AssociateDavid Roberts - President & DirectorMichael Petusky - Managing DirectorRick Wise - Managing Director - Medical Technology & SuppliesDaniel Stauder - Director - Equity Research Conference Call Participants Michael Sarcone - AnalystFrank Takkinen - Senior Research AnalystJim Sidoti - AnalystBrett Fishbin - Vice President & ...
DMC (BOOM) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
DMC Global (BOOM) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Geoff High - Vice President, Investor Relations & Corporate CommunicationsJames O'Leary - Interim President & CEO, Executive Chairman & DirectorEric Walter - Chief Financial OfficerStephen Gengaro - Managing Director Conference Call Participants Gerard Sweeney - Managing Director & Senior Research AnalystKen Newman - VP & Equity Research Analyst Operator and welcome to the DMC Global First Quarter twenty twenty five Earnin ...
Velocity Financial(VEL) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
Velocity Financial (VEL) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Christopher Oltmann - Treasurer & Director of Investor RelationsChristopher Farrar - Co-Founder, CEO & DirectorMark Szczepaniak - Chief Financial OfficerEric Hagen - Managing Director Conference Call Participants Don Fandetti - AnalystSteven Delaney - Analyst Operator Good day, and welcome to Velocity Financial Inc. First Quarter twenty twenty five Conference Call. All participants will be in listen only mode. After ...
Cable One(CABO) - 2025 Q1 - Earnings Call Transcript
2025-05-01 22:02
Cable One (CABO) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Company Participants Jordan Morkert - VP - Investor RelationsJulie Laulis - Chair, President & Chief Executive OfficerTodd Koetje - Chief Financial OfficerFrank Louthan - Managing Director Conference Call Participants Sebastiano Petti - Senior Research AnalystBrandon Nispel - Director & Equity Research Analyst Operator Thank you for standing by. My name is Rebecca, and I will be your conference operator today. At this time, I would like to welc ...
Intuitive(ISRG) - 2025 FY - Earnings Call Transcript
2025-05-01 22:00
Financial Data and Key Metrics Changes - The company reported a 19% year-over-year revenue growth, with a procedure growth rate of 17% [70][68] - The install base growth was 15%, indicating strong demand for the company's products [71] - Gross margins were noted as not perfect, with guidance set between 15% to 17% [71] Business Line Data and Key Metrics Changes - The SP product line saw a significant procedure growth of 94% year-over-year, indicating strong adoption [72] - General surgery has become the largest segment, with healthy growth across all segments [74] - The company has over 11,000 platforms operating in clinical environments, with a total of approximately 18 million procedures performed lifetime [57] Market Data and Key Metrics Changes - The company experienced strength in US General Surgery, with great adoption by general surgeons [65] - There has been a decrease in bariatric surgery due to the rise of GLP-1 drugs, but the company believes this will stabilize over time [63] - The company is present in 70 countries, indicating a broad market reach [85] Company Strategy and Development Direction - The company focuses on delivering value for patients and ensuring that healthcare providers receive value from their products [45] - There is an emphasis on expanding indications and launching new platforms, including the da Vinci V [60] - The company aims to achieve digital excellence and enhance its supply chain capabilities [91] Management's Comments on Operating Environment and Future Outlook - Management acknowledged environmental uncertainties in China and the impact of healthcare worker strikes globally [62][64] - The company is optimistic about the future, with a focus on innovation and growth despite current challenges [61] - Management highlighted the importance of a mission-driven employee population to achieve long-term goals [49] Other Important Information - The company has a strong Net Promoter Score of 75, indicating high customer satisfaction [87] - The company is committed to leveraging artificial intelligence and data analytics to improve surgical outcomes [103] Q&A Session All Questions and Answers Question: Are there any issues with tariffs affecting product sales in China? - The company faces a 125% tariff on products manufactured in the U.S. and imported into China, which has a significant financial impact [96] Question: What is being done to minimize the impact of tariffs? - The company is evaluating its supply chain operations and workflows to mitigate the impact of tariffs while waiting for the trade environment to stabilize [101] Question: How is the company leveraging AI and data analytics? - The company is focused on accessing high-quality data and using it for customer hospital analytics to optimize surgical outcomes [106][107] Question: What are the company's capital allocation priorities over the next two to three years? - The company prioritizes organic investment in the business, looking for technology acquisition opportunities, and returning excess cash to shareholders opportunistically [118]